Mycobacterium tuberculosis and HIV co-infection in the lung: Synergic immune dysregulation leading to disease progression

Monaldi Archives for Chest Disease

Volumn 55, Issue 5, 2000, Pages 381-388

  Bocchino, M ^a   Sanduzzi, A ^a   Bariffi, F ^a  

^a MONALDI HOSPITAL   (Italy)

Author keywords

Chemokines; Cytokines; HIV; Lung; Mycobacterium tuberculosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 8; LIPOARABINOMANNAN; MONOCYTE CHEMOTACTIC PROTEIN; PROTEINASE INHIBITOR; RANTES; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELLULAR IMMUNITY; COMORBIDITY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; GRANULOMATOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION RISK; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; RISK FACTOR; SURVIVAL TIME;

EID: 0034493825     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. The neglected global tuberculosis problem: A report of the 1992 world congress on tuberculosis
2. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
3. The impact of HIV infection on the global epidemiology of tuberculosis
4. Resurgence of tuberculosis and the impact of HIV infection
5. The host immune response to tuberculosis
6. Of microbes and macrophages: Entry, survival and persistance
7. Immune mechanisms of protection
8. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1
9. Defining the requirements for immunological control of mycobacterial infections
10. Regulatory and effector functions of cytokines in tuberculosis
11. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis
12. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
13. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen-specific adaptive immunity
14. T cell mediated immunity to Mycobacterium tuberculosis
15. Increased absolute number but not proportion of gamma/delta T-lymphocytes in the bronchoalveolar fluid of patients with active pulmonary tuberculosis
16. Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection
17. Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens
18. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis
19. Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10
20. Regulation of immune responses by TGF-β
21. HIV and the lung. State of the Art
22. Alveolar macrophages from patients with HIV-1 infection express accessory molecules, activation markers and release increased amounts of biological response modifiers
23. Macrophage tropism: Fact or fiction?
24. Programmed death of T cells in HIV-1 infection
25. HIV infection of macrophages and pathogenesis of AIDS dementia complex: Interaction of the host cell and viral genotype
26. HIV-1 infection of lung alveolar fibroblasts and macrophages in humans
27. CD8+ lymphocytes in the lung of AIDS patients harbour human immunodeficiency virus-type 1
28. Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis
29. Release of GM-CSF by alveolar macrophages in the lung of HIV-1 infected patients. A mechanism accounting for macrophages and neutrophil accumulation
30. Expression of TNF-alpha receptors by T cells membrane TNF-alpha by alveolar macrophages suggests a role for TNF-alpha in the regulation of the local immune response in the lung of HIV-1 infected patients
31. Interleukin-1 and tumor necrosis factor-alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to CD4 receptors
32. Tumor necrosis factor receptors expression and signal transduction in HIV-1 infected cells
33. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression
34. Serum levels of tumor necrosis factor-alpha and soluble TNF receptors in human immunodeficiency virus type-1 infection: Correlations to clinical, immunologic, and virologic parameters
35. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection
36. Tuberculosis in HIV-positive patients: Cellular response and immune activation in the lung
37. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people
38. Tuberculosis in patients with human immunodeficiency virus infection
39. Mechanisms of latency in Mycobacterium tuberculosis
40. Lymphocyte dynamics, apoptosis and HIV infection
41. Relationship of the manifestations of tuberculosis to CD4 cell count in patients with immunodeficiency virus infection
42. Functional activity of alveolar and peripheral cells in patients with human acquired immunodeficiency syndrome and pulmonary tuberculosis
43. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis
44. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men
45. Comparative histopathological study of pulmonary tuberculosis in HIV-infected patients
46. The emergency of drug-resistant tuberculosis in New York City
47. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda
48. Mycobaterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung
49. Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells
50. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV
51. Mycobacterium tuberculosis and its purified derivative activate expression of the human immunodeficiency virus
52. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type-1
53. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
54. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the terminal repeat
55. Transcription factors NF-IL-6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8
56. Effect of isoniazid prophilaxis on incidence of active tuberculosis and progression of human immunodeficiency virus infection
57. Functional diversity of helper T lymphocytes
58. Biology of human TH1 and TH2 cells
59. Local immune responses correlate with presentation and outcome in tuberculosis
60. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis
61. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients
62. Interleukin 12 at the site of disease in tuberculosis
63. Increased numbers of interleukin-12-producing cells in human tuberculosis
64. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
65. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis
66. Th1-Th2 hypothesis of HIV infection: New insights
67. Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection
68. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals: Decreased IFN-γ in the presence of preserved IL-4 production
69. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection
70. Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation
71. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection
72. Altered cytokine production and accessory cell function after HIV-1 infection
73. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens
74. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice
75. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure
76. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
77. Differential production of interleukin-10 during immunodeficiency virus infection
78. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage
79. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation
80. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
81. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes
82. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection
83. Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: An indirect interleukin-10-mediated effect
84. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression
85. Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production
86. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma)
87. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus
88. Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors
89. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals
90. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin-12 and anti-IL-10
91. T helper type 1/T helper type 2 cytokines and T cell death: Preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons
92. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
93. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
94. Inhibition of IL-12 production by human monocyte-derived macrophages by TNF
95. The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines
96. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: Analysis of underlying mechanisms and modulation with therapy
97. Chemokines: A new classification system and their role in immunity
98. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients
99. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis
100. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: A possible role for mycobacterial lipoarabinomannan
101. Chemokine receptors and chemokines in HIV infection
102. T-cell subset: Chemokine receptors guide the way
103. Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis
104. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis
105. Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: Lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells
106. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to non-peptidic mycobacterial antigens in asymptomatic HIV-1-infected persons
107. Macrophage apoptosis in mycobacterial infections
108. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection
109. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
110. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior anti-retroviral therapy
111. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations
112. Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens
113. A randomized trial of high-versus low-dose subcutaneous interleukin-2 out-patient therapy for early human immunodeficiency virus type 1 infection
114. Organ specific cytokine therapy: Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung
115. Treatment of multi-drug resistance tuberculosis with interferon-gamma via aerosol
116. Cytokine therapeutics: Lessons from interferon alpha
117. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis